- Home
- AAP vs AGIO Comparison
AAP vs AGIO Comparison
Compare AAP & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAP
- AGIO
- Stock Information
- Founded
- AAP 1929
- AGIO 2007
- Country
- AAP United States
- AGIO United States
- Employees
- AAP N/A
- AGIO N/A
- Industry
- AAP Auto & Home Supply Stores
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- AAP Consumer Discretionary
- AGIO Health Care
- Exchange
- AAP Nasdaq
- AGIO Nasdaq
- Market Cap
- AAP 2.0B
- AGIO 2.0B
- IPO Year
- AAP N/A
- AGIO 2013
- Fundamental
- Price
- AAP $38.93
- AGIO $30.28
- Analyst Decision
- AAP Hold
- AGIO Buy
- Analyst Count
- AAP 16
- AGIO 8
- Target Price
- AAP $44.38
- AGIO $56.57
- AVG Volume (30 Days)
- AAP 2.6M
- AGIO 637.9K
- Earning Date
- AAP 02-26-2025
- AGIO 05-01-2025
- Dividend Yield
- AAP 2.57%
- AGIO N/A
- EPS Growth
- AAP N/A
- AGIO N/A
- EPS
- AAP N/A
- AGIO 11.64
- Revenue
- AAP $9,094,327,000.00
- AGIO $36,498,000.00
- Revenue This Year
- AAP N/A
- AGIO $50.61
- Revenue Next Year
- AAP $1.20
- AGIO $223.79
- P/E Ratio
- AAP N/A
- AGIO $2.60
- Revenue Growth
- AAP N/A
- AGIO 36.07
- 52 Week Low
- AAP $33.08
- AGIO $27.14
- 52 Week High
- AAP $86.47
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- AAP 49.33
- AGIO 39.54
- Support Level
- AAP $37.03
- AGIO $30.00
- Resistance Level
- AAP $41.67
- AGIO $32.90
- Average True Range (ATR)
- AAP 1.69
- AGIO 1.22
- MACD
- AAP 0.60
- AGIO -0.08
- Stochastic Oscillator
- AAP 54.56
- AGIO 9.12
About AAP Advance Auto Parts Inc.
Advance Auto Parts Inc is an automotive aftermarket parts provider in North America, serving both professional installers (professional) and do it yourself (DIY) customers, as well as independently owned operators. The Company's stores and branches offer a range selection of brand names, original equipment manufacturer (OEM) and owned brand automotive replacement parts, accessories, batteries and maintenance items for domestic and imported cars, vans, sport utility vehicles and light and heavy-duty trucks.eds.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.